Sarepta Therapeutics Zooms Higher on Early Data Rally Promising
Sarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
This guide highlights dividend ETFs with the lowest expense ratios and explains how expense structures influence long-term performance.
26,982 articlesSarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
AMD pulled back after a strong rally as investors weigh the impact of the CIQ Linux partnership on AI and data center...
AI is changing how and where we work, but the tools ahead disruption already exist to soften the impact. This report ...
A political clash at the Milan Cortina Games after Trump described a U.S. Olympian as a 'real Loser' has ignited a de...
Zillow reports a strong start to 2026 with rising revenue and a bold pre-marketing push. The Zillow Preview program d...
Trump signals possible U.S. ground action against Mexican cartels, sending ripples through defense stocks and supply ...
Bank of America economists say the Fed is unlikely to cut rates until 2027, a forecast that could influence mortgages...
Trump visits China this week as tariffs linger and midterm politics shape strategy. Investors weigh whether china off...
A grounded, practical look at whether Micron Technology stock can move meaningfully in the next 12 months. Explore dr...
Mortgage rates move higher for a second straight week, delaying any spring surge in activity. Analysts say inflation ...
Wednesday’s top analyst calls push trading as investors weigh inflation data, Fed policy, and AI-driven peers. AMD, J...
A leading voice in personal finance questions the premise of hitting a $1 million target by age 25, urging young adul...